“…Furthermore, bioprinting, as a type of additive manufacturing, is amenable to scaled up tissue fabrication and manufacturing, an important consideration as clinical use of fabricated tissues increases (Wu et al, 2017;Skylar-Scott et al, 2019;Castilho et al, 2020). The development of materials compatible with cells and other biologics, so called "bioinks" has also exploded involving a variety of artificial and native material types (Chimene et al, 2016;Chan et al, 2020;Cui et al, 2020), material sourcing (Abaci and Guvendiren, 2020), curing features (GhavamiNejad et al, 2020), and utilities (Whitford and Hoying, 2016;Unagolla and Jayasuriya, 2020). While the practical aspects and applications involving bioprinting are actively explored (as indicated by the recent burst of informative reviews on bioprinting and bioinks), the integration of biological responses and dynamics in bioprinted systems are less addressed.…”